Diabetes Glossary I – JU

 

Source: Dr Green.org (Diabetes Glossary)

 

http://www.drgreene.org/body.cfm

 

IDDM (insulin-dependent diabetes mellitus): Former term for type 1 diabetes

 

Immune system: The body’s system for protecting itself from viruses and bacteria or any “foreign” substances

 

Immunosuppressant: A drug that suppresses the natural immune responses. Immunosuppressants are given to transplant patients to prevent organ rejection or to patients with autoimmune diseases.

 

Impaired fasting glucose (IFG): A condition in which a blood glucose test, taken after an 8- to 12-hour fast, shows a level of glucose higher than normal but not high enough for a diagnosis of diabetes. IFG, also called pre-diabetes, is a level of 110 mg/dL to 125 mg/dL. Most people with pre-diabetes are at increased risk for developing type 2 diabetes

 

Impaired glucose tolerance (IGT): A condition in which blood glucose levels are higher than normal but are not high enough for a diagnosis of diabetes. IGT, also called pre-diabetes, is a level of 140 mg/dL to 199 mg/dL 2 hours after the start of an oral glucose tolerance test. Most people with pre-diabetes are at increased risk for developing type 2 diabetes. Other names for IGT that are no longer used are “borderline,” “subclinical,” “chemical,” or “latent” diabetes

 

Implantable insulin pump: A small pump placed inside the body to deliver insulin in response to remote-control commands from the user

 

Impotence: The inability to get or maintain an erection for sexual activity. Also called erectile (ee-REK-tile) dysfunction (dis-FUNK-shun)

 

Incontinence: Loss of bladder or bowel control; the accidental loss of urine or feces

 

Inhaled insulin: A treatment for taking insulin using a portable device that allows a person to breathe in insulin

 

Injection: Inserting liquid medication or nutrients into the body with a syringe. A person with diabetes may use short needles or pinch the skin and inject at an angle to avoid an intramuscular injection of insulin

 

Injection site rotation: Changing the places on the body where insulin is injected. Rotation prevents the formation of lipodystrophies

 

Injection sites: Places on the body where insulin is usually injected

 

Insulin: A hormone that helps the body use glucose for energy. The beta cells of the pancreas make insulin. When the body cannot make enough insulin, insulin is taken by injection or through use of an insulin pump.

 

Insulin adjustment: A change in the amount of insulin a person with diabetes takes based on factors such as meal planning, activity, and blood glucose levels.

Insulin-dependent diabetes mellitus (IDDM): Former term for type 1 diabetes

 

Insulinoma: A tumor of the beta cells in the pancreas. An insulinoma may cause the body to make extra insulin, leading to hypoglycemia

 

Insulin pen: A device for injecting insulin that looks like a fountain pen and holds replaceable cartridges of insulin. Also available in disposable form

 

Insulin pump: An insulin-delivering device about the size of a deck of cards that can be worn on a belt or kept in a pocket. An insulin pump connects to narrow, flexible plastic tubing that ends with a needle inserted just under the skin. Users set the pump to give a steady trickle or basal amount of insulin continuously throughout the day. Pumps release bolus doses of insulin (several units at a time) at meals and at times when blood glucose is too high, based on programming done by the user

 

Insulin reaction: When the level of glucose in the blood is too low (at or below 70 mg/dL). Also known as hypoglycemia

 

Insulin receptors: Areas on the outer part of a cell that allow the cell to bind with insulin in the blood. When the cell and insulin bind, the cell can take glucose from the blood and use it for energy

 

Insulin resistance: The body’s inability to respond to and use the insulin it produces. Insulin resistance may be linked to obesity, hypertension, and high levels of fat in the blood

 

Insulin shock: See hypoglycemia

 

Intensive therapy: A treatment for diabetes in which blood glucose is kept as close to normal as possible through frequent injections or use of an insulin pump; meal planning; adjustment of medicines; and exercise based on blood glucose test results and frequent contact with a person’s health care team

 

Intermediate-acting insulin: A type of insulin that starts to lower blood glucose within 1 to 2 hours after injection and has its strongest effect 6 to 12 hours after injection, depending on the type used. See lente insulin and NPH insulin

 

Intramuscular injection: Inserting liquid medication into a muscle with a syringe. Glucagon may be given by subcutaneous or intramuscular injection for hypoglycemia

 

Islet cell auto antibodies (ICA): Proteins found in the blood of people newly diagnosed with type 1 diabetes. They are also found in people who may be developing type 1 diabetes. The presence of ICA indicates that the body’s immune system has been damaging beta cells in the pancreas

 

Islet transplantation: Moving the islets from a donor pancreas into a person whose pancreas has stopped producing insulin. Beta cells in the islets make the insulin that the body needs for using blood glucose

 

Islets: Groups of cells located in the pancreas that make hormones that help the body break down and use food. For example, alpha cells make glucagon and beta cells make insulin. Also called islets of Langerhans

 

Islets of Langerhans: See islets

 

Jet injector: A device that uses high pressure instead of a needle to propel insulin through the skin and into the body

 

Juvenile diabetes: Former term for insulin-dependent diabetes mellitus (IDDM), or type 1 diabetes

  

 

Tags: IDDM (insulin-dependent diabetes mellitus), Immune system, Immunosuppressant, Impaired fasting glucose (IFG), Impaired glucose tolerance (IGT), Implantable insulin pump, Impotence, Incontinence, Inhaled insulin, Injection, Injection site rotation, Injection sites, Insulin, Insulin adjustment, Insulin pen, Insulin pump, Insulin reaction, Insulin receptors, Insulin resistance, Insulin shock, Insulinoma, Intensive therapy, Intermediate-acting insulin, Intramuscular injection, Islet cell auto antibodies (ICA), Islet transplantation, Islets, Islets of Langerhans, Jet injector, Juvenile diabetes

Trackback URI | Comments RSS